Proteomics of immune cells from liver tumors reveals immunotherapy targets
The immune system helps protect us against cancer, however immune cells often become dysfunctional within the tumor environment, which leads to disease progression. Elucidating the mechanisms by which immune cells lose their functional capacity in tumors is critical to developing next-generation immunotherapies. The Geiger laboratory at the IRB used mass spectrometry-based proteomics to profile immune […]
New strategic infectious disease research collaboration between the IRB and The Rockefeller University
The Institute for Research in Biomedicine (IRB) in Bellinzona and The Rockefeller University in New York announced the beginning of an important strategic collaboration to advance infectious disease research. As demonstrated by the Covid-19 pandemic, scientific research is increasingly interdisciplinary and international collaborations between leading centers facilitate significant discoveries that help scientists better understand disease […]
The circadian immune system in cancer
International PhD Program in Immunology, Cell Biology and Biochemistry 2022/2023 Prof. Christoph Scheiermann University of Geneva (CH) and Ludwig-Maximilians-University Munich (D) Tuesday, June 13, 2023 at 12 pm Bios+ Seminar Room Contact: Prof. Mariagrazia Uguccioni
From (membrane) protein interactions to precision medicine
IRB Special Seminar Prof. Igor Stagljar Department of Molecular Genetics, Department of Biochemistry, Faculty of Medicine, University of Toronto (CA) Wednesday, June 14, 2023 at 12 pm Bios+ Seminar Room Contact: Prof. Roger Geiger
Therapeutic opportunities in age-related diseases
IRB Special Seminar Prof. Fabrizio d’Adda di Fagagna Principal Investigator at IFOM ETS, The AIRC Institute of Molecular Oncology, Milan and at IGM, Institute of Molecular Genetics, CNR, Pavia (IT) Tuesday, May 30, 2023 at 3 pm Bios+ Seminar Room Contact: Prof. Petr Cejka
Bios+: Professor Franco Cavalli appointed president
The Bellinzona Institutes of Science (Bios+) association composed of two members – the Institute for Research in Biomedicine (IRB) and the Oncology Research Institute (IOR), affiliated to the Università della Svizzera italiana (USI) – has ratified the appointment of Prof. Franco Cavalli as president for the next two years. The rotation, which according to the […]
A new Research Group at the IRB led by Dr. Caroline Junqueira
It is now official: Caroline Junqueira, PhD, will join the Institute for Research in Biomedicine (IRB) starting August 1, 2023. With her arrival, the IRB will have a new Group Leader who will develop her research program in the field of immunology and infectious diseases, a central topic of IRB research. This will further strengthen […]
New IRB study: finding on the influence of Myc in NK cells
This collaborative study, mainly centered at Bios+ (Bellinzona Institutes of Science), reveals the importance of the transcription factor and proto-oncogene Myc in maintaining Natural Killer (NK) cells’ development, translational machinery, and anticancer immunity. The data, published in the Life Science Alliance Journal, are relevant when considering the potential side effects and benefits of long sought-after […]
More than 150 participants at the Castelgrande Lecture with Prof. Alberto Mantovani
A resounding success.” This is how one can sum up the public event staged last Wednesday, May 3, in Bellinzona that was attended by more than 150 people, including experts in the field and members of civil society. Theme of the evening: “Immunity and Vaccines, from Cancer to Covid-19.” Bellinzona, May 3, 2023 – The […]
Understanding and targeting blood vessels in colon cancer
International PhD Program in Immunology, Cell Biology and Biochemistry 2022/2023 Prof. Tatiana Petrova Associate Director for Research, Laboratory Vascular and tumor biology, Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne (CH) Thursday, May 11, 2023 at 12 pm Bios+ Seminar Room Contact: Marcus Thelen
